These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24669756)

  • 1. Advances in targeted delivery of small interfering RNA using simple bioconjugates.
    Nielsen C; Kjems J; Sørensen KR; Engelholm LH; Behrendt N
    Expert Opin Drug Deliv; 2014 May; 11(5):791-822. PubMed ID: 24669756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.
    Tai W
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31200490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprotein-Mediated siRNA Delivery.
    Bäumer N; Berdel WE; Bäumer S
    Mol Pharm; 2017 May; 14(5):1339-1351. PubMed ID: 28170265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic face of RNAi: in vivo challenges.
    Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
    Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-viral nanosystems for systemic siRNA delivery.
    David S; Pitard B; Benoît JP; Passirani C
    Pharmacol Res; 2010 Aug; 62(2):100-14. PubMed ID: 20006707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA.
    Zhi D; Zhao Y; Cui S; Chen H; Zhang S
    Acta Biomater; 2016 May; 36():21-41. PubMed ID: 27045350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of siRNA delivery to target sites: issues and future directions.
    Khalil IA; Yamada Y; Harashima H
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1053-1065. PubMed ID: 30198792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery strategies and potential targets for siRNA in major cancer types.
    Lee SJ; Kim MJ; Kwon IC; Roberts TM
    Adv Drug Deliv Rev; 2016 Sep; 104():2-15. PubMed ID: 27259398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for improving the specificity of siRNAs for enhanced therapeutic potential.
    Gatta AK; Hariharapura RC; Udupa N; Reddy MS; Josyula VR
    Expert Opin Drug Discov; 2018 Aug; 13(8):709-725. PubMed ID: 29902093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.
    Fathabadi EG; Shelling AN; Al-Kassas R
    Expert Opin Drug Deliv; 2012 Jul; 9(7):743-54. PubMed ID: 22657869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.
    Gindy ME; Leone AM; Cunningham JJ
    Expert Opin Drug Deliv; 2012 Feb; 9(2):171-82. PubMed ID: 22251440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for tumor-directed delivery of siRNA.
    Chowdhury EH
    Expert Opin Drug Deliv; 2011 Mar; 8(3):389-401. PubMed ID: 21314230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple, noninvasive and efficient method for transdermal delivery of siRNA.
    Lin CM; Huang K; Zeng Y; Chen XC; Wang S; Li Y
    Arch Dermatol Res; 2012 Mar; 304(2):139-44. PubMed ID: 22009459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.